Status:
COMPLETED
Rehabilitation Through Hippotherapy for the Management of Women After Primary Treatment of Breast Cancer
Lead Sponsor:
Alliance Equiphoria
Collaborating Sponsors:
Institut Equiphoria - La Canourgue, France
Montpellier Institut du Sein - Montpellier, France
Conditions:
Breast Cancer Female
Side Effects
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
Breast cancer is the most common women's cancer and the third leading cause of death. Advances in prevention, detection and primary treatment have improved overall survival leading to its growing acce...
Detailed Description
Following the announcement and evolution of breast cancer, but also in response to primary treatment, some symptoms appear to directly compromise the psychic and/or physical sphere of the individual. ...
Eligibility Criteria
Inclusion
- Confirmed histological diagnosis of breast cancer staging \[T1-T3, N0-N2 and M0\]
- Patient already scheduled or ongoing treatment for surgery and/or chemotherapy and/or hormone therapy and/or radiotherapy
- Having consulted a physician of the Care and Support Unit of the MIS during its health care
- WHO performance index from 0 to 2
- Able to give her informed consent in writing
- Able to complete questionnaires
- Abduction of the hip necessary and sufficient (to allow horse riding)
- Affiliated to a social security scheme
- Certificate of no contraindication issued by the physician in charge
Exclusion
- History of malignant tumors in the last 5 years with the exception of basocellular skin carcinoma or squamous cell carcinoma
- Breast cancer as a secondary diagnosis
- Medication intake or presence of conditions associated with fatigue (e.g. chronic fatigue syndrome)
- Concomitant and uncontrolled severe degenerative or chronic disease
- History of allergic reactions to dust and/or horsehair, or asthma
- Contraindications to physical activity
- History of horseback riding or hippotherapeutic treatment during the last 6 months
- Clinically significant cognitive impairment or dementia
- Pregnancy and breastfeeding
- Majors protected by law
- Patient participating in another biomedical research or in exclusion period
Key Trial Info
Start Date :
April 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2022
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT04350398
Start Date
April 20 2017
End Date
August 30 2022
Last Update
October 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Equiphoria
La Canourgue, France, 48500